SCHEMBL950247

SCHEMBL950247

CC(C)(O)CCC#N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28756047 0.82
SCHEMBL30156594 0.81 ALDH1A1 (0.43)
SCHEMBL11435605 0.78
SCHEMBL10065705 0.78 MEN1 (0.35)
SCHEMBL25184627 0.75 ALDH1A1 (0.44)
SCHEMBL14907 0.75
SCHEMBL8485451 0.72
SCHEMBL8844796 0.71 ALDH1A1 (0.39)
SCHEMBL21842102 0.71 ALDH1A1 (0.39)
SCHEMBL4067657 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3268740-B1 POLYPEPTIDE ARRAYS AND METHODS OF ATTACHING POLYPEPTIDES TO AN ARRAY VIBRANT HOLDINGS LLC (US) 2022-11-09 EP claimed
CN-106008159-B A kind of separation method of isopropanol-propionitrile mixture 济南大学 2019-01-22 CN claimed
CN-106008159-A Method for separating isopropyl alcohol-propionitrile mixture 济南大学 2016-10-12 CN claimed
US-12624033-B2 KRAS inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2026-05-12 US disclosed
US-20260125400-A1 TYK2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS INC (US) 2026-05-07 US disclosed
US-20260042800-A1 ANTIMICROBIAL PEPTIDOMIMETICS BASILEA PHARMACEUTICA INT AG ALLSCHWIL (CH) 2026-02-12 US disclosed
US-12486290-B2 Isoindolinone and indazole compounds for the degradation of EGFR C4 THERAPEUTICS, INC. (US) 2025-12-02 US disclosed
US-20250361237-A1 1,4-DIHYDROBENZO[D]PYRAZOLO[3,4-F][1,3]DIAZEPINE DERIVATIVES AND RELATED COMPOUNDS AS LRRK2, NUAK1 AND/OR TYK2 KINASE MODULATORS FOR THE TREATMENT OF E.G. AUTOIMMUNE DISEASE ORIGENIS GMBH (DE) 2025-11-27 US disclosed
US-12435086-B2 Synthesis of heterocyclic compounds PLEXXIKON INC. (US) 2025-10-07 US disclosed
US-20250270234-A1 ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR C4 THERAPEUTICS, INC. (US) 2025-08-28 US disclosed
US-12384788-B2 1,4-dihydrobenzo[d]pyrazolo[3,4-f][1,3]diazepine derivatives and related compounds as LRRK2, NUAK1 and/or TYK2 kinase modulators for the treatment of e.g. autoimmune disease ORIGENIS GMBH (DE) 2025-08-12 US disclosed
EP-0471493-B1 N,N',N'-trisubstituted-5-bisaminomethylene-1,3-dioxane-4,6-dione inhibitors of acyl-CoA:cholesterol-acyl transferase AMERICAN HOME PROD (US) 1996-05-22 EP disclosed
US-5399697-A N,N',N'-trisubstituted-5-bisaminomethylene-1,3-dioxane-4,6-dione inhibitors of acyl-CoA:cholesterol-acyl transferase AMERICAN HOME PRODUCTS CORPORATION (US) 1995-03-21 US disclosed
US-5380853-A Atherosclerosis AMERICAN HOME PRODUCTS CORPORATION (US) 1995-01-10 US disclosed
US-5281714-A Enzyme inhibitors or antioxidants AMERICAN HOME PRODUCTS CORPORATION (US) 1994-01-25 US disclosed
US-5179216-A Anticholesterol agents and atherosclerosis AMERICAN HOME PRODUCTS CORPORATION (US) 1993-01-12 US disclosed
EP-0471493-A1 N,N',N'-trisubstituted-5-bisaminomethylene-1,3-dioxane-4,6-dione inhibitors of acyl-CoA:cholesterol-acyl transferase AMERICAN HOME PRODUCTS CORPORATION (US) 1992-02-19 EP disclosed
US-4493801-A Preparation of tertiary alcohols BASF AKTIENGESELLSCHAFT (DE) 1985-01-15 US disclosed
EP-0053262-B1 PROCESS FOR THE PREPARATION OF TERTIARY ALCOHOLS BASF Aktiengesellschaft (DE) 1983-12-28 EP disclosed
EP-0033898-A1 Process for preparing aqueous polyurethane dispersions BASF Aktiengesellschaft (DE) 1981-08-19 EP disclosed